# To Evaluate the Efficacy of Alirocumab for Neoatherosclerosis by Using OCT, in Comparison With Standard Statin Therapy

> **NCT03533959** · — · UNKNOWN · sponsor: **Kobe University** · enrollment: 31 (estimated)

## Conditions studied

- Coronary Artery Disease Progression

## Interventions

- **DRUG:** Alirocumab

## Key facts

- **NCT ID:** NCT03533959
- **Lead sponsor:** Kobe University
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-18
- **Primary completion:** 2020-12
- **Final completion:** 2025-12
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2018-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03533959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03533959, "To Evaluate the Efficacy of Alirocumab for Neoatherosclerosis by Using OCT, in Comparison With Standard Statin Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03533959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*